Gelteq Ltd

Gelteq Ltd (GELS) priced its initial public offering on Oct 22, 2024 at $4.00 per share, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $37.8M. Benchmark was lead-left underwriter. Ellenoff Grossman & Schole advised the company.

Gelteq Ltd develops and commercializes white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. Its edible gels are rebranded by other companies and span five verticals: pets, sports, pharmaceutical, over-the-counter and nutraceutical.

Status

IPO

Ticker

GELS

Exchange

Nasdaq Capital Market

Priced

Oct 22, 2024

IPO price

$4.00

Market cap at IPO price

$37.8M

First filed

Aug 30, 2022

Underwriters

Benchmark

Company counsel

Ellenoff Grossman & Schole

Sector

Biotech & pharma

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.